About COVID-19 vaccine data

All data comes from the Aotearoa Immunisation Register (AIR).

  • Metrics on this page can use 1 of 2 views of the data.
  • Operational view — shows all doses administered in New Zealand.

Person view — shows the vaccination status of people regardless of how that was recorded or whether it was in New Zealand.

Those who have been vaccinated overseas will only appear in the person view. The person view includes all people that are currently alive and in AIR.

On 12 June 2024, the estimated population was changed to be sourced from AIR instead of the most recent Health Service User (HSU).


COVID-19 vaccinations summary

Metric Total
Second boosters administered 1,151,301
Total doses administered 14,446,102
First boosters administered 2,793,342
Percentage of 12 years and older who have completed primary course 81.5%
Percentage of eligible 50 years and older who have received second booster 57.2%
Percentage of eligible 18 years and older who have received first booster 70.3%

Total vaccinations

This table is an operational view.

Definitions

Cumulative total: All vaccinations that have been administered and entered into the AIR and including Sunday 05 July 2026.

Vaccinations last week: Over the 7 days up to and including Sunday 05 July 2026.

Dose Vaccinations last week Cumulative total
Primary course doses (12 and older) 65 8,031,785
Booster 1 70 2,793,342
Booster 2 286 1,151,301
Booster 3+ 4,369 2,036,917
Paediatric first dose 3 273,214
Paediatric second dose 1 159,097
Infant first dose 0 187
Infant second dose 0 150
Infant third dose 0 109
Total doses 4,794 14,446,102


Booster breakdowns

These tables are a person view.

Booster counts by ethnicity

Ethnicity Booster 1 (16 to 17) Booster 1 (18 and older) Booster 2 (50 and older)
Māori 170 260,865 71,564
Pacific Peoples 64 155,115 30,841
Asian 176 471,916 71,371
Other 951 1,789,501 709,532
Total 1,361 2,677,397 883,308

Booster 2 uptake by age group

Age group Eligible Received Uptake
30 to 34 196,555 40,899 20.8%
35 to 49 647,478 145,993 22.5%
50 to 64 717,023 287,422 40.1%
65 and older 826,942 595,886 72.1%


Vaccine uptake percentage by age band

This bar graph shows current COVID-19 vaccination uptake by age band, with bars separated into 3 categories.

  1. Individuals fully vaccinated.
  2. Individuals partially vaccinated.
  3. Individuals unvaccinated.

This graph shows that:

  • all of the older age groups from age group 45 to 49 and above have surpassed 90% of individuals being fully vaccinated
  • for ages between 18 and 44, between 70% and 90 % of individuals are fully vaccinated
  • for ages between 5 to 17 the fully vaccinated percentage is below 50%.
Bar graph showing COVID-19 vaccine uptake percentage by age band.

Vaccine uptake percentage by district of residence 12 years and older

This bar graph shows current COVID-19 vaccination uptake by district of residence for ages 12 and above, with bars separated into 3 categories.

  1. Individuals fully vaccinated.
  2. Individuals partially vaccinated.
  3. Individuals unvaccinated.

This graph shows that all districts have a relatively similar percentage of individuals fully vaccinated, all between 70% and 90%.

These figures do not include tamariki aged 0 to 11.

Vaccine uptake percentage by district of residence 12 years and older image block

Vaccinations by week

This stacked column graph shows the number of COVID-19 vaccinations by week from the week ending 21 February 2021 until the most recent week ending Sunday.

This graph shows:

  • the highest peak of vaccinations around August to October 2021
  • a second large peak around January to February 2022.

During the first peak there were approximately 400,000 to 500,000 vaccinations each week. While during the second peak there were approximately 200,000 to 400,000 vaccinations each week.

After these 2 peaks the number of vaccinations remains significantly lower, with less than 100,000 vaccinations in any given week. This graph is also broken down with the colour of the stacks in each column representing the type of dose:

  • primary course
  • first booster
  • second booster
  • third booster +
  • paediatric first
  • paediatric second.

The first peak consisted of primary course doses while the second peak consisted mostly of first booster doses. From:

  • June to December 2022 the vast majority of vaccinations were second boosters
  • early 2023 most vaccinations are third boosters or higher.
Bar graph of COVID-19 vaccinations by week, up to 5 July 2026.

Adverse events following immunisations (AEFI)

Like all medicines, the COVID-19 vaccine may cause side effects in some people. These side effects:

  • are common
  • are usually mild
  • do not last long
  • will not stop people from having the second dose or going about daily life.

Serious allergic reactions do happen but are extremely rare.

Suspected AEFI to COVID-19 vaccines are reported to the Centre for Adverse Reactions Monitoring (CARM). While Medsafe no longer publishes their COVID-19 vaccine safety reports, they continue to monitor reports of adverse reactions submitted to CARM.

Centre for Adverse Reactions Monitoring (CARM) — University of Otagoexternal link

COVID-19 archive — Medsafeexternal link